Home › NDC Lookup › RxCUI directory › RxCUI 313762

Zaleplon 5 MG Oral Capsule — RxCUI 313762

RxNorm drug concept · Semantic clinical drug
RxCUI 313762 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313762
Official nameZaleplon 5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped22
Reported Medicaid activity (SDUD)33,889 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zaleplon: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zaleplon is designed specifically to help you fall asleep faster, not to keep you asleep longer. Studies have shown it reduces the time it takes to drift off, but it hasn't been pr...
  • What exactly does zaleplon do — will it keep me asleep all night?
  • Take zaleplon right before you get into bed, or after you've already gone to bed but can't fall asleep. Try to take it on an empty stomach or with a very light snack. A heavy, high...
  • When should I take it, and does it matter if I eat first?
📖 Read our full Zaleplon guide →

🕸️ Concept Web — How Zaleplon 5 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zaleplon 5 MG Oral Capsule RxCUI 313762

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zaleplon 74667
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zaleplon Oral Capsule 374609
    • Zaleplon Oral Product 1165265
    • Zaleplon Pill 1165266
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Zaleplon 5 MG 330413

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zaleplon 5 MG SCDC · 330413
  • Zaleplon Oral Capsule SCDF · 374609
  • Zaleplon Oral Product SCDG · 1165265
  • Zaleplon Pill SCDG · 1165266

📦 FDA Products & Package NDCs

12 products · 22 package NDCs
22 package NDCs map to RxCUI 313762 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0084-25 100 CAPSULE in 1 BOTTLE (0054-0084-25) Zaleplon Hikma Pharmaceuticals USA Inc. 2008-06-06
00054-0085-25 100 CAPSULE in 1 BOTTLE (0054-0085-25) Zaleplon Hikma Pharmaceuticals USA Inc. 2008-06-06
29300-0131-01 100 CAPSULE in 1 BOTTLE, PLASTIC (29300-131-01) zaleplon Unichem Pharmaceuticals (USA), Inc. 2009-05-05
29300-0131-05 500 CAPSULE in 1 BOTTLE, PLASTIC (29300-131-05) zaleplon Unichem Pharmaceuticals (USA), Inc. 2009-05-05
29300-0131-13 30 CAPSULE in 1 BOTTLE, PLASTIC (29300-131-13) zaleplon Unichem Pharmaceuticals (USA), Inc. 2009-05-05
29300-0132-01 100 CAPSULE in 1 BOTTLE, PLASTIC (29300-132-01) zaleplon Unichem Pharmaceuticals (USA), Inc. 2009-05-05
29300-0132-05 500 CAPSULE in 1 BOTTLE, PLASTIC (29300-132-05) zaleplon Unichem Pharmaceuticals (USA), Inc. 2009-05-05
29300-0132-10 1000 CAPSULE in 1 BOTTLE, PLASTIC (29300-132-10) zaleplon Unichem Pharmaceuticals (USA), Inc. 2009-05-05
43063-0505-30 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-505-30) ZALEPLON PD-Rx Pharmaceuticals, Inc. 2013-05-17
57237-0239-01 100 CAPSULE in 1 BOTTLE (57237-239-01) ZALEPLON Rising Pharma Holdings, Inc. 2008-06-06
57237-0240-01 100 CAPSULE in 1 BOTTLE (57237-240-01) ZALEPLON Rising Pharma Holdings, Inc. 2008-06-06
65862-0214-01 100 CAPSULE in 1 BOTTLE (65862-214-01) ZALEPLON Aurobindo Pharma Limited 2008-06-06
65862-0214-05 500 CAPSULE in 1 BOTTLE (65862-214-05) ZALEPLON Aurobindo Pharma Limited 2008-06-06
65862-0215-01 100 CAPSULE in 1 BOTTLE (65862-215-01) ZALEPLON Aurobindo Pharma Limited 2008-06-06
65862-0215-05 500 CAPSULE in 1 BOTTLE (65862-215-05) ZALEPLON Aurobindo Pharma Limited 2008-06-06
69452-0364-20 100 CAPSULE in 1 BOTTLE (69452-364-20) Zaleplon Bionpharma Inc. 2024-02-17
69452-0365-20 100 CAPSULE in 1 BOTTLE (69452-365-20) Zaleplon Bionpharma Inc. 2024-02-17
71335-0236-01 30 CAPSULE in 1 BOTTLE (71335-0236-1) zaleplon Bryant Ranch Prepack 2019-05-08
71335-0236-02 60 CAPSULE in 1 BOTTLE (71335-0236-2) zaleplon Bryant Ranch Prepack 2018-03-23
71335-0236-03 90 CAPSULE in 1 BOTTLE (71335-0236-3) zaleplon Bryant Ranch Prepack 2021-12-27
71335-0236-04 20 CAPSULE in 1 BOTTLE (71335-0236-4) zaleplon Bryant Ranch Prepack 2021-12-27
71335-0236-05 28 CAPSULE in 1 BOTTLE (71335-0236-5) zaleplon Bryant Ranch Prepack 2021-12-27
Observed labelers: Unichem Pharmaceuticals (USA), Inc. (6) · Bryant Ranch Prepack (5) · Aurobindo Pharma Limited (4) · Bionpharma Inc. (2) · Hikma Pharmaceuticals USA Inc. (2) · Rising Pharma Holdings, Inc. (2) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.